Compare DexCom, Inc. (DXCM) vs Motorola Solutions Inc (MSI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Motorola Solutions Inc — how do they compare? DexCom, Inc. trades at $84.11 (market cap $31.86B), while Motorola Solutions Inc trades at $444.18 (market cap $74.00B). The key difference: Motorola Solutions Inc is far larger — about 2.3× DexCom, Inc.'s market cap, and Motorola Solutions Inc pays a 1.08% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and Motorola Solutions Inc for 100 Days on average.
| DXCM | MSI | |
|---|---|---|
Market Cap | $31.86B | $74.00B |
Volume | 3,607,070 | 722,147 |
Sector | Health | Technology |
52-Week High | $92.34 | $491.24 |
52-Week Low | $54.84 | $363.83 |
Typical Hold Time | 62 Days | 100 Days |
Enterprise Value | $31.32B | $82.90B |
Dividend Yield | — | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $84.41, showing modest daily gains of 0.13%. The stock demonstrates strong fundamental performance with consistent earnings beats and robust revenue growth, reaching $4.66 billion in 2025. Technical indicators show a bearish short-term trend with key support at $82. The company maintains impressive profitability with 20.12% net margins and 38.49% ROE, supported by growing adoption of CGM technology in diabetes care.
DXCM presents a compelling growth story with expanding market opportunities in Type 2 diabetes care. Analyst consensus remains strongly bullish with 81% buy ratings and $95.07 price target, suggesting 13% upside. Key risks include reimbursement challenges and competitive pressures. The company's strong cash flow generation and institutional support provide solid foundation for continued growth.
MSI (Motorola Solutions) trades at $447.12, down 0.3% on the day, with a bearish technical signal but strong fundamentals. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $4.41 surpassing the $3.85 estimate. Revenue grew to $11.68B in 2025, and net income margin improved to 17.44%. Recent news highlights expansion in defense and public safety contracts, including a $139 million Louisiana deal and a $1.5B acquisition of D-Fend Solutions.
Outlook remains positive driven by a record $15.6B backlog and strategic acquisitions, though high valuation ratios (P/E 35.23) and significant investing cash outflows pose risks. Analyst consensus is bullish with a $525.86 price target, implying 17.6% upside, but investors should monitor debt levels and integration of recent purchases.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Motorola Solutions Inc
Motorola Solutions, Inc. is a data communications and telecommunications equipment provider. The Company develops data capture, wireless, infrastructure, bar code scanning, two-way radios, and wireless broadband networks. Motorola also produces public safety and government products, voice and data communications products and systems, and wireless LAN securities.
Read more on MSI →
